Jagged1 contributes to the drug resistance of Jurkat cells in contact with human umbilical cord-derived mesenchymal stem cells

Oncology Letters

Volumn 6, Issue 4, 2013, Pages 1000-1006

  Yuan, Yin ^a,b   Lu, Xin ^c   Chen, Xuan ^b   Shao, Hongwei ^b   Huang, Shulin ^b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

^c SOUTH CHINA NORMAL UNIVERSITY   (China)

Author keywords

Apoptosis; Jagged1; Mesenchymal stem cells; T cell acute lymphoblastic leukemia

Indexed keywords

5' NUCLEOTIDASE; BETA1 INTEGRIN; CD28 ANTIGEN; ENDOGLIN; HERMES ANTIGEN; JAGGED1; NEUTRALIZING ANTIBODY; NOTCH1 RECEPTOR; THY 1 ANTIGEN;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; DRUG SENSITIVITY; FLOW CYTOMETRY; GENE AMPLIFICATION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL; TISSUE CHARACTERIZATION; UMBILICAL CORD; UPREGULATION;

EID: 84881570187     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1523     Document Type: Article

References (34)

1. Pui CH, Relling MV and Downing JR: Acute lymphoblastic leukemia. N Engl J Med. 350: 1535-1548, 2004.
2. De Keersmaecker K, Marynen P and Cools J: Genetic insights in the pathogenesis of T-cell acute lymphoblastic leukemia. Haematologica 90: 1116-1127, 2005.
3. Weng AP, Ferrando AA, Lee W, et al: Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science306: 269-271, 2004.
4. Zhu YM, Zhao WL, Fu JF, et al: NOTCH1 mutations in T-cell acute lymphoblastic leukemia: prognostic significance and implication in multifactorial leukemogenesis. Clin Cancer Res12: 3043-3049, 2006.
5. Allman D, Punt JA, Izon DJ, Aster JC and Pear WS: An invitation to T and more: notch signaling in lymphopoiesis. Cell 109: S1-S11, 2002.
6. Radtke F, Fasnacht N and MacDonald HR: Notch signaling in the immune system. Immunity 32: 14-27, 2010.
7. Liang R, Huang GS, Wang Z, et al: Effects of human bone marrow stromal cell line (HFCL) on the proliferation, differentiation and apoptosis of acute myeloid leukemia cell lines U937, HL-60 and HL-60/VCR. Int J Hematol 87: 152-166, 2008.
8. Nefedova Y, Landowski TH and Dalton WS: Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms. Leukemia 17: 1175-1182, 2003.
9. Nefedova Y, Cheng P, Alsina M, Dalton WS and GabrilovicDI: Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines. Blood 103: 3503-3510, 2004.
10. Carlesso N, Aster JC, Sklar J and Scadden DT: Notch1-induced delay of human hematopoietic progenitor cell differentiation is associated with altered cell cycle kinetics. Blood 93: 838-848, 1999.
11. Sade H, Krishna S and Sarin A: The anti-apoptotic effect of Notch-1 requires p56lck-dependent, Akt/PKB-mediated signaling in T cells. J Biol Chem. 279: 2937-2944, 2004.
12. Rutz S, Mordmüller B, Sakano S and Scheffold A: Notch ligands Delta-like1, Delta-like4 and Jagged1 differentially regulate activation of peripheral T helper cells. Eur J Immunol 35: 2443-2451, 2005.
13. Friedenstein AJ, Petrakova KV, Kurolesova AI and FrolovaGP: Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 6: 230-247, 1968.
14. Rebelatto CK, Aguiar AM, Moretão MP, et al: Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue. Exp Biol Med (Maywood) 233: 901-913, 2008.
15. Rao MS and Mattson MP: Stem cells and aging: expanding the possibilities. Mech Ageing Dev 122: 713-734, 2001.
16. Romanov YA, Svintsitskaya VA and Smirnov VN: Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells 21: 105-110, 2003.
17. Phinney DG and Prockop DJ: Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Stem Cells 25: 2896-2902, 2007.
18. Ball LM, Bernardo ME, Roelofs H, et al: Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood 110: 2764-2767, 2007.
19. Le Blanc K, Rasmusson I, Sundberg B, et al: Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363: 1439-1441, 2004.
20. Baksh D, Yao R and Tuan RS: Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 25: 1384-1392, 2007.
21. Scupoli MT, Perbellini O, Krampera M, Vinante F, Cioffi F and Pizzolo G: Interleukin 7 requirement for survival of T-cell acute lymphoblastic leukemia and human thymocytes on bone marrow stroma. Haematologica 92: 264-266, 2007.
22. Ning H, Yang F, Jiang M, et al: The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study. Leukemia 22: 593-599, 2008.
23. Apelqvist A, Li H, Sommer L, et al: Notch signalling controls pancreatic cell differentiation. Nature 400: 877-881, 1999.
24. Lobov I, Renard R, Papadopoulos N, et al: Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting. Proc Natl Acad Sci USA 104: 3219-3224, 2007.
25. Loomes KM, Stevens SA, O'Brien ML, et al: Dll3 and Notch1 genetic interactions model axial segmental and craniofacial malformations of human birth defects. Dev Dyn 236: 2943-2951, 2007.
26. Ascano JM, Beverly LJ and Capobianco AJ: The C-terminal PDZ-ligand of JAGGED1 is essential for cellular transformation. J Biol Chem 278: 8771-8779, 2003.
27. Docheva D, Haasters F and Schieker M: Mesenchymal stem cells and their cell surface receptors. Curr Rheumatol Rev 4: 155-160, 2008.
28. Calvi LM, Adams GB, Weibrecht KW, et al: Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425: 841-846, 2003.
29. Liotta F, Angeli R, Cosmi L, et al: Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling. Stem Cells 26: 279-289, 2008.
30. Kurpinski K, Lam H, Chu J, et al: Transforming growth factor-beta and notch signaling mediate stem cell differentiation into smooth muscle cells. Stem Cells 28: 734-742, 2010.
31. Chen L: Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol 4: 336-347, 2004.
32. Chadwick N, Zeef L, Portillo V, et al: Identification of novel Notch target genes in T cell leukaemia. Mol Cancer 8: 35, 2009.
33. van den Brandt J, Wang D and Reichardt HM: Resistance of single-positive thymocytes to glucocorticoid-induced apoptosis is mediated by CD28 signaling. Mol Endocrinol 18: 687-695, 2004.
34. Boise LH, Minn AJ, Noel PJ, et al: CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity 3: 87-98, 1995.